AzTrials
AzTrials

Cardiac SurgeryNCT05142176

Bilateral Erector Spinae Plane Block for Management of Acute Postoperative Pain After Pediatric Cardiac Surgeries Through a Midline Sternotomy

A study testing Erector spinae catheters insertion and Postoperative pain management in people with Cardiac Surgery, run by Tanta University.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Many analgesic modalities have been investigated in pediatrics. The analgesic efficacy of bilateral ultrasound-guided erector spinae plane block in pediatric patients undergoing open midline sternotomy will be examined. Read more about this study

Who is it for?
Ages 3 to 12 years
Conditions the study is for
Cardiac Surgery
What is being tested?
Erector spinae catheters insertion and Postoperative pain management
Type of treatment
Injection or infusion
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
75 participants
Where
No sites listed yet
Study dates
5 Feb 2022to 30 Mar 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 3 to 12 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • children undergoing cardiac surgical procedures through midline sternotomy

Who cannot join

  • The patients with preoperative ejection fraction <35%
  • allergic to the amide type of local anesthetics (LA)
  • preoperative inotropic support

About this study

Many analgesic modalities have been investigated in pediatrics. The analgesic efficacy of bilateral ultrasound-guided erector spinae plane block in pediatric patients undergoing open midline sternotomy will be examined. Methods: 60 patients aged 3- 12 years will be randomly assigned into two groups: Control group will receive general anesthesia with bilateral sham erector spinae plane block at the level of T6 transverse process using 0.3 ml/kg normal saline on each side. Erector spinae plane block group will receive bilateral ultrasound-guided erector spinae plane block at the level of T6 transverse process using 0.3 ml/kg bupivacaine 0.25% (on each side) with a maximum dose of 2 mg/kg. The postoperative pain was assessed using Modified Objective Pain Scores (MOPS) which will be evaluated at 0, 1, 2, 4, 6, 8, 10, and 12 hours after extubation, total consumption of intraoperative fentanyl (1µg/kg IV in case of inadequate analgesia), time to first rescue analgesic administration and postoperative paracetamol consumption will be recorded over the first 24 hours postoperatively.

Read the detailed description

75 children with an American Society of Anesthesiologists physical status class I and II undergoing cardiac surgical procedures through midline sternotomy . The patients with preoperative ejection fraction <35%, low-cardiac-output syndrome, recurrent ventricular arrhythmias, preoperative inotropic support, allergic to the amide type of local anesthetics (LA), requiring intubation for more than 3 hours or re-exploration, and requiring redo or emergency surgery will be excluded from the study. The enrolled children will be subsequently randomized into 2 groups using a computer generated random number table: Control group will receive general anesthesia with bilateral sham erector spinae plane block at the level of T6 transverse process using 0.3 ml/kg normal saline on each side. Erector spinae plane block group will receive bilateral ultrasound-guided erector spinae plane block at the level of T6 transverse process using 0.3 ml/kg bupivacaine 0.25% (on each side) with a maximum dose of 2 mg/kg. The postoperative pain will be managed with rescue intravenous (IV) fentanyl. Both the groups will receive IV acetaminophen 15 mg/kg every 8 hours as a component of multimodal analgesia. A routine preoperative assessment will be performed for all the patients. Premedication in the form of 1 mg/kg promethazine syrup will be administered, 1 hour before shifting to the operating room. Standard American Society of Anesthesiologists monitoring will be instituted and the children were anesthetized as per institutional protocol. The protocol constituted an induction with sevoflurane in oxygen 50% and air, peripheral IV cannulation of appropriate size followed by IV midazolam, 0.05 to 0.1 mg/kg, fentanyl, l to 2 mg/kg, and rocuronium, 0.6 mg/kg, to facilitate endotracheal intubation. Femoral arterial access will be established for intra-arterial pressure monitoring. Central venous catheter will be inserted in the right internal jugular vein for central venous pressure monitoring in addition to the temperature, end-tidal carbon dioxide, and near infrared spectroscopy monitoring. Anesthesia will be maintained with sevoflurane (0.9-2%) in 50% oxygen in air mixture and supplemental boluses of 0.1 mg/kg of atracurium, with the hemodynamics maintained within 20% of the baseline. Ultrasound-Guided ESPB The ESPB will be performed with the child in a right lateral decubitus position under aseptic precautions. A high frequency (6-13 MHz) linear ultrasound transducer (Sonosite Inc, Bothell WA) was placed in a longitudinal orientation over the T3 transverse process lateral to the spinous process. After identifying the muscles (trapezius, rhomboid major, and erector spinae) above the hyperechoic transverse process image, a 5-cm 22- guage Stimuplex A block needle (B. Braun, Melsungen, Germany) will be inserted in-plane in a cephalo-caudad direction. The endpoint will be defined as the needle pointing to the tip of transverse process piercing the erector spinae muscle. The LA will be deposited at this position, close to the costotransverse foramen. The needle tip position will be confirmed by hydrolocation with 0.5 to 1 mL of 1% lidocaine indicating linear fluid spread lifting the fascial plane between the transverse process and erector spinae muscle. After careful negative aspiration, 1.5 mg/kg of 0.2% ropivacaine will be administered under ultrasound guidance . The process will be repeated with injection of 0.3 ml/kg bupivacaine 0.25%bupivacaine on the contralateral side adding up to a cumulative dose of 2 mg/kg ropivacaine. Following sternotomy, adequate heparinization will be achieved with a resultant activated clotting time >480 seconds before the initiation of cardiopulmonary bypass in both the groups. After a satisfactory surgical correction, the patient will be weaned off cardiopulmonary bypass followed by protamine administration. The patients will be transferred to the intensive care unit (ICU) after completion of the procedure.

Postoperative ICU Management and Postoperative Pain Assessment The electrocardiogram, invasive blood pressure, respiratory rate, and pulse oximetry (Spo2) were monitored and recorded throughout the postoperative period. The study subjects will be extubated within 2 to 3 hours postoperatively once the exubation criteria (conscious, hemodynamically stable, (peak inspiratory pressure) PIP <20 cmH2O above positive end-expiratory pressure (PEEP)will be fulfilled, no neuromuscular blockade, and normal arterial blood gas analysis). Postoperative pain assessment will be performed using Modified Objective Pain Score (MOPS)9 at 0, 1, 2, 4, 6, 8, 10, and12hours post extubation. Acetaminophen, 15 mg/kg, IV, every 8 hours will be administered in both the groups. . A rescue analgesic fentanyl, 0.5 to 1 mg/kg, will be administered when the MOPS score was≥ 4 at rest. Postoperative adverse effects such as nausea, vomiting, cardiac arrhythmia, and complications such as LA toxicity, and vascular puncture were recorded and treated. Statistical Analysis Primary and Secondary Endpoints MOPS at 0, 1, 2, 4, 6, 8, 10, and 12 hours post extubation constituted the primary endpoints. The secondary endpoints will include intraoperative fentanyl requirement, extubation time, time to first rescue analgesic requirement, postoperative cumulative fentanyl requirement up to 12 hours, Ramsay sedation score, ICU stay, and incidence of adverse events.

Conditions
Cardiac Surgery
Being tested
Erector spinae catheters insertion, Postoperative pain management

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Erector spinae catheters insertionOther

    Ultrasound-Guided ESPB The ESPB will be performed with the child in a right lateral decubitus position under aseptic precautions by a high frequency (6-13 MHz) linear ultrasound transducer

  • Postoperative pain managementDrug

    IV acetaminophen 15 mg/kg every 8 hours as a component of multimodal analgesia.

Study groups in NCT05142176
Study groupRoleWhat they receive
control groupPlacebo comparatorwill receive general anesthesia with bilateral sham erector spinae plane block at the level of T6 transverse process using 0.3 ml/kg normal saline on each side.
Receives: Other: Erector spinae catheters insertion; Drug: Postoperative pain management
Erector spinae plane block groupActive comparatorwill receive bilateral ultrasound-guided erector spinae plane block at the level of T6 transverse process using 0.3 ml/kg bupivacaine 0.25% (on each side) with a maximum dose of 2 mg/kg.
Receives: Other: Erector spinae catheters insertion; Drug: Postoperative pain management

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Modified Objective Pain Score (MOPS)0

    A rescue analgesic fentanyl, 0.5 to 1 mg/kg, will be administered when the MOPS score was≥ 4 at rest

    Measured: at immediately post extubation.

  2. Modified Objective Pain Score (MOPS)1

    A rescue analgesic fentanyl, 0.5 to 1 mg/kg, will be administered when the MOPS score was≥ 4 at rest

    Measured: at1 hour post extubation.

  3. Modified Objective Pain Score (MOPS)2

    A rescue analgesic fentanyl, 0.5 to 1 mg/kg, will be administered when the MOPS score was≥ 4 at rest

    Measured: at 2 hour post extubation.

  4. Modified Objective Pain Score (MOPS)3

    A rescue analgesic fentanyl, 0.5 to 1 mg/kg, will be administered when the MOPS score was≥ 4 at rest

    Measured: at 4 hour post extubation.

  5. Modified Objective Pain Score (MOPS)4

    A rescue analgesic fentanyl, 0.5 to 1 mg/kg, will be administered when the MOPS score was≥ 4 at rest

    Measured: at 6 hour post extubation.

  6. Modified Objective Pain Score (MOPS)5

    A rescue analgesic fentanyl, 0.5 to 1 mg/kg, will be administered when the MOPS score was≥ 4 at rest

    Measured: at 8 hour post extubation.

  7. Modified Objective Pain Score (MOPS)6

    A rescue analgesic fentanyl, 0.5 to 1 mg/kg, will be administered when the MOPS score was≥ 4 at rest

    Measured: at 12 hour post extubation.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted2 Dec 2021
  2. Study start5 Feb 2022 (estimated)
  3. Primary completion30 Mar 2022 (estimated)
  4. Study completion30 Mar 2022 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Model description
Bilateral erector spinae block
Masking
Double blind
Who is masked
Participant, Care provider
Enrolment
75 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05142176
Sponsor's protocol ID
34774/7/21
Status last verified
Dec 2021
First submitted
6 Nov 2021
Last updated
1 Feb 2022
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Erector spinae catheters insertion and Postoperative pain management in people with Cardiac Surgery, run by Tanta University.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 1 Feb 2022. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Modified Objective Pain Score (MOPS)0 (time frame: at immediately post extubation.). The study lists 7 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 Feb 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in